Pediatric Demyelination

Continuum (Minneapolis, Minn.)
|June 5, 2016
PubMed

Insights

This review aids clinicians in diagnosing and treating pediatric acquired demyelinating syndromes. It details specific features and offers a general approach for evaluating these neurological disorders in children.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Demyelinating Disorders

Background:

  • Acquired demyelinating syndromes in children require precise diagnostic and therapeutic strategies.
  • Understanding the expanding phenotype of these conditions is crucial for effective management.

Observation:

  • Consensus definitions have improved recognition and understanding of pediatric acquired demyelinating syndromes.
  • Clinical and radiologic features, prognosis, and treatment responses are increasingly well-characterized.
  • Case studies illustrate the diverse presentations of these syndromes.

Findings:

  • This review provides a structured approach to the evaluation of pediatric demyelination.
  • It highlights key diagnostic features and treatment considerations for acquired demyelinating syndromes.
  • Emerging therapies for chronic demyelinating disorders like multiple sclerosis and neuromyelitis optica spectrum disorder require further investigation.

Implications:

  • Clinicians can better identify and manage pediatric acquired demyelinating syndromes.
  • Enhanced understanding supports improved patient outcomes and prognosis.
  • Ongoing research and clinical trials are vital for advancing treatment options.
Abstract

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
9.1K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
16
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
2.0K